Factors predicting Cosmesis (CA), Late effects (LE) and Patient reported outcome measures (PROM) in high-risk breast cancer (BC) treated with hypo-fractionated radiotherapy (HF-WBI): real world outcomes from a developing country
Research Square (Research Square)